TheStreet.com recently ran an article outlining five companies that Warren Buffett holds in his portfolio that yield 3% or better.
Keep Reading →
May 20 - News
With the SPDR S&P Biotech Index up 38% over the trailing-12-month period, it's evident that investment dollars are willingly flowing into the biotech sector.
Keep Reading →
May 20 - News
There's good news and bad news for Americans. The good news is that the age-adjusted death rate in the U.S.
Keep Reading →
May 20 - News
AstraZeneca plc (ADR) (NYSE:AZN)'s in a tight spot.
Keep Reading →
May 15 - News
As part of the split, the pharmaceutical company looks poised to turn its current drug-marketing joint venture with London-based GlaxoSmithKline plc (ADR) (NYSE:GSK) into an...
Keep Reading →
May 15 - News
Gilead Sciences, Inc. (NASDAQ:GILD) reported a relatively rare earnings miss in the first quarter on May 2.
Keep Reading →
May 14 - News
Back towards the end of April 2013, Theravance Inc (NASDAQ:THRX) surprised everyone when it announced plans to split into two separate companies.
Keep Reading →
May 14 - News
LONDON -- The FTSE 100 set a five-and-a-half-year record of 6,638 points last Friday, and though the index is down from that today at 6,617, it still looks like hanging on to...
Keep Reading →
May 13 - News
Overall, the market is seeing red today. The Dow Jones Industrial Average (Dow Jones Indices:.DJI) is down 36 points as of 11 a.m. EDT, with little momentum to push it higher.
Keep Reading →
May 13 - News
A study published in The New England Journal of Medicine testing omega-3 fatty acids -- commonly found in fish oil -- in patients with risk factors for cardiovascular disease ...
Keep Reading →
May 13 - News
With the SPDR S&P Biotech Index up 32% over the trailing-12-month period, it's evident that investment dollars are willingly flowing into the biotech sector.
Keep Reading →
May 13 - News
LONDON -- Dividend income accounts for around two-thirds of total returns, the actual rate of return taking into account both capital and income appreciation.
Keep Reading →
May 12 - News
The words of the great big-band leader Duke Ellington came to mind after hearing the first quarter results from Sarepta Therapeutics Inc (NASDAQ:SRPT) : "It don't mean a thing...
Keep Reading →
May 9 - News
Exchange-traded funds are all the rage these days, and for good reason.
Keep Reading →
May 8 - News
GlaxoSmithKline plc (ADR) (NYSE:GSK) is a pharmaceutical and healthcare company headquartered in the United Kingdom.
Keep Reading →
May 6 - News
The best thing about the stock market is that you can make money in either direction. Historically, stock indexes have tended to trend up over the long term.
Keep Reading →
May 6 - News
As I noted nine weeks ago, cancer statistics are both staggering and disappointing.
Keep Reading →
May 6 - News
Every Sunday I make it a point to examine a combination of earnings stories or Food and Drug Administration panel reviews or PDUFA decisions in the upcoming week that you can'...
Keep Reading →
May 5 - News
LONDON -- If you want to be eligible for a dividend payment, or if you're hoping a share price might drop disproportionately when the time has passed, you need to be aware of ...
Keep Reading →
May 4 - News
The problem was the other drugs didn't make up nearly enough of the Singulair loss.
Keep Reading →
May 3 - News
The market for prescription and over-the-counter drugs is huge and hugely profitable.
Keep Reading →
May 2 - News
As the market continues to climb, investors are beginning to see thinning dividend yields on many of their big pharma shares.
Keep Reading →
May 1 - Dividend Stocks, News
LONDON -- While crippling austerity in Europe and fiscal obstacles could put the brake on growth rates there, in developing regions a backdrop of accommodative central bank action...
Keep Reading →
May 1 - News
Dividend stocks can be a great addition to your portfolio, especially pharmaceutical dividend stocks that offer a bit of stability in rocky times.
Keep Reading →
May 1 - News
Would you hold a pharmaceutical product presentation in Hooters? That's just one of many alleged instances that the U.S.
Keep Reading →
May 1 - News
Big pharma is a controversial industry. Along with tobacco companies, they are some of the most vilified businesses in the world.
Keep Reading →
May 1 - News
In it's earnings call for last quarter, online retailer Amazon.com, Inc.
Keep Reading →
May 1 - News
Throughout the years, some of the best performing pharmaceutical industry stocks have had long histories of providing healthy dividends to their stockholders. Merck & Co., Inc...
Keep Reading →
April 30 - News
Patent expiration is one of the major issues faced by pharma companies, which increases the competition from generic medicines and eventually leads to downfall in their sales.
Keep Reading →
April 30 - News
One of the nice things about owning biotech companies is the large number of acquisitions in the sector.
Keep Reading →
April 30 - News
It’s not just about offering a better drug, but it’s also about launching it at the right time in the market.
Keep Reading →
April 28 - News
LONDON -- Back in January, I was looking to name (and shame) the five worst stocks on the FTSE 100 (INDEXFTSE:UKX), when my eyes alighted on GlaxoSmithKline plc (ADR) (GSK) (NYSE...
Keep Reading →
April 26 - News
Following in the footsteps of Abbott Laboratories (NYSE:ABT) spinning out its drug division into AbbVie Inc (NYSE:ABBV), and Pfizer spinning out its animal health division into...
Keep Reading →
April 26 - News
Editor's Note: Related Tickers: Amarin Corporation plc (ADR) (NASDAQ:AMRN), GlaxoSmithKline plc (ADR) (NYSE:GSK), Abbott Laboratories (NYSE:ABT), Valeant Pharmaceuticals Intl ...
Keep Reading →
April 23 - News
Northern Trust Corporation (NASDAQ:NTRS) FlexShares unit rolled out the International Quality Dividend Defensive Index Fund on Tuesday as part of a trio of new dividend ETFs with...
Keep Reading →
April 22 - Stock Analysis
With the SPDR S&P Biotech Index up 37% over the trailing-12-month period, it's evident that investment dollars are willingly flowing into the biotech sector.
Keep Reading →
April 20 - News
Editor's Note: Related tickers: Theravance Inc (NASDAQ:THRX), GlaxoSmithKline plc (NYSE:GSK), Travelzoo Inc. (NASDAQ:TZOO), Arch Coal Inc (NYSE:ACI), Overstock.com, Inc.
Keep Reading →
April 18 - News
LONDON -- Next week is a busy week for news from FTSE 100 (INDEXFTSE:UKX) companies as first-quarter results time for those whose years end in December approaches -- and it ...
Keep Reading →
April 18 - News
Although we don't believe in timing the market or panicking over market movements, we do like to keep an eye on big changes -- just in case they're material to our investing thesis...
Keep Reading →
April 18 - News
So much for the big correction.
Keep Reading →
April 17 - News
There is always something interesting happening in the Bio-Pharma sector due to a number of firms working on several new drugs.
Keep Reading →
April 16 - News
Editor's Note: Related tickers: Theravance Inc (NASDAQ:THRX), VIVUS, Inc. (NASDAQ:VVUS), Amgen, Inc.
Keep Reading →
April 15 - News
I hope to pinpoint the very best buying opportunities in today's uncertain market, as well as highlight those shares I feel you should hold...
Keep Reading →
April 15 - News
Editor's Note: Related tickers: JPMorgan Chase & Co. (NYSE:JPM), Wells Fargo & Company (NYSE:WFC), Citigroup Inc.
Keep Reading →
April 15 - News
Earnings season is getting ready to rev into high gear, but earnings are unlikely to be the talk of the sector in the days to come, with three big Food and Drug Administration...
Keep Reading →
April 14 - News
The process of developing a drug from start to finish is incredibly arduous, usually involves around $1 billion in costs, and can take upwards of a decade to complete.
Keep Reading →
April 12 - News
LONDON -- After offering my pick of our telecom companies last week, today I'm turning my attention to the FTSE 100 Pharmaceuticals and Biotechnology sector.
Keep Reading →
April 12 - News
Looking for solid dividends? The health care sector has plenty of dividend stocks to choose from.
Keep Reading →
April 12 - News
LONDON -- The FTSE 100 has been off its highs for the past month, having set a new five-year record of 6,534 points on March 12.
Keep Reading →
April 11 - News
In this series I'm subjecting companies to scrutiny under five headings: prospects, performance, management, safety and valuation.
Keep Reading →
April 10 - News